| Place of Origin: | China |
|---|---|
| Brand Name: | HNB |
| Certification: | ISO |
| Model Number: | HNB-Chloroquine diphosphate |
| Minimum Order Quantity: | 1KG |
| Price: | Negotiable |
| Packaging Details: | Aluminum foil bag |
| Delivery Time: | Usually7-10days |
| Payment Terms: | L/C, D/A, D/P, T/T, , MoneyGram |
| Supply Ability: | 5000kg/Month |
| CAS: | 50-63-5 | Mf: | C18H32ClN3O8P2 |
|---|---|---|---|
| MW: | 515.862 | Specification: | ≥98% |
| Appearance: | White Powder | Purity: | 99%,99%min |
| Shelf Life: | 2 Years | Grade: | Medical Grade,Phamaceutical Grade,Medicine & Tech,USP BP FCC EP |
Veterinary API Antimalarial CAS 50-63-5 Chloroquine phosphate powder
The Introductction
| Product Name: | Chloroquine diphosphate |
| Synonyms: |
acide phosphorique - N-(7-chloroquinoléin-4-yl)-N,N-diéthylpentane-1,4-diamine (2:1) |
| CAS: | 50-63-5 |
| MF: | C18H32ClN3O8P2 |
| MW: | 515.862 |
The Application & Function
Chloroquine phosphate, also known as N ',N '-diethyl-N4 -(7-chloro-4-quinolinyl)-1, 4-pentenediamine diphosphate, is used to treat chloroquine-sensitive malaria such as falciparum malaria and Vivax malaria. It can also be used to treat the treatment of parenteral amebiasis, as well as anti-rheumatism.
According to the study, the drug was found to be effective at the cellular level in inhibiting the infection of the novel coronavirus 2019-nCoV that broke out in Wuhan.
Limited to falciparum malaria sensitive to this drug, vivax malaria and other malaria (resistant to this drug strains widely appeared at home and abroad), but also used in the treatment of enteral amebiasis, as well as anti-rheumatism.
The COA
| Item | Specification | Results |
| APPEARANCE | WHITE | CONFORMS |
| SOLUBILITY | FREELY SOLUBLE IN CHLOROFORM;SOLUBLE IN WATER OR METHANOL;INSOLUBLE IN ER | CONFORMS |
| PH | 5.0-7.2 | 6.51 |
| LOSS ON DRYING | ≤4.5% | 3.10% |
| RESIDUEON IGNITION | ≤2.5% | 0.281% |
| HEAVY METALS | ≤20PPM | <15PPM |
| TYRAMINE | ≤0.35% | 0.051% |
| RELATED COMPOSITIONS | TYLOSIN A ≥80% A+B+C+D ≥95% | 93% 98% |
| Conclusion | Confirm with the standard |
